Corient Private Wealth’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Sell
3,672
-11,487
-76% -$758K ﹤0.01% 2638
2026
Q1
$1.04M Buy
15,159
+12,003
+380% +$938K ﹤0.01% 1642
2025
Q4
$278K Sell
3,156
-10
-0.3% -$851 ﹤0.01% 2220
2025
Q3
$264K Sell
3,166
-2,464
-44% -$215K ﹤0.01% 2200
2025
Q2
$526K Buy
5,630
+2,787
+98% +$264K ﹤0.01% 1678
2025
Q1
$301K Sell
2,843
-18
-0.6% -$1.86K ﹤0.01% 1852
2024
Q4
$277K Sell
2,861
-96
-3% -$9.57K ﹤0.01% 1940
2024
Q3
$292K Buy
2,957
+48
+2% +$4.39K ﹤0.01% 2026
2024
Q2
$250K Sell
2,909
-26
-0.9% -$2.04K ﹤0.01% 2009
2024
Q1
$222K Buy
2,935
+154
+6% +$11.9K ﹤0.01% 2050
2023
Q4
$211K Buy
+2,781
New +$194K ﹤0.01% 2050
2023
Q3
Sell
-2,480
Closed -$207K 2203
2023
Q2
$207K Buy
+2,480
New +$202K ﹤0.01% 1861

Other funds holding MMSI

Corient Private Wealth's MMSI Position: Q2 2026 in Review

Corient Private Wealth reduced its Merit Medical Systems (MMSI) stake by 76% in Q2 2026, selling an estimated $758K and leaving 3,672 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

Corient Private Wealth first reported a position in MMSI in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.04M in Q1 2026. 403 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Corient Private Wealth held 3,672 shares of Merit Medical Systems worth $255K as of Q2 2026.
  • Corient Private Wealth sold 11,487 Merit Medical Systems shares in Q2 2026, an estimated $758K.
  • Merit Medical Systems made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2638 holding.
  • Corient Private Wealth first reported a position in Merit Medical Systems in Q2 2023 and has held it in 12 quarters since.
  • Corient Private Wealth's Merit Medical Systems position peaked at $1.04M in Q1 2026.
  • 403 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.